Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by 99942Apophis on Feb 06, 2021 1:24pm

Reddit

I like the idea of reddit and have to agree with a few posters here now isn't the time, someone posted we should wait until indisputable hard numbers are out at either 30 days, 60, or 90 days don't particularly want to wait for 180 seems too long. We all know currently it's still speculation to many but as confident as we are in going forward that (TLT) will hit it out of the ball park let's just wait for the numbers to back us up otherwise it won't have the necessary momentum
Comment by Johnandrose22 on Feb 06, 2021 3:14pm
I continue to believe that results associated with patients 13 and 14 will be crucial to the life of this company. Although seemingly clinically insignificant (only 2 of a proposed 25-100 patients), If these patients received the optimal dosage/protocol from the beginning of treatment and their 6 month results indicate CR they will have established, in concert with Phase I patients 5 & 6, that ...more  
Comment by 99942Apophis on Feb 06, 2021 3:56pm
Yes Johnandrose your words echo the thoughts of many posters here and if we see some expected results in the spring perhaps there will also be spring in our steps lol
Comment by Rumpl3StiltSkin on Feb 06, 2021 6:57pm
Do we know that this kind of naked shorting is going to be outlawed in Canada? That may help things along, or maybe it will slow us down?!?
Comment by fredgoodwinson on Feb 06, 2021 7:13pm
Well said John.
Comment by enriquesuave on Feb 06, 2021 7:32pm
Actually it's more like the last 6 patients treated which we have to look out for that is patients 9-14.  Patients 9,10,11 and 12 got a second treatment which was optimized, and 13 &14 will end up having both 1st and second treatments optimized.  If we get 4 out of these particular 6 to be CR at 12 months then we can expect even higher CR rates going forward as all other patients ...more  
Comment by Kingpin68 on Feb 06, 2021 9:57pm
Did the company ever say why the 5 patients were withdrawn from the study. Does anyone know ?
Comment by Pandora on Feb 07, 2021 2:23am
From the July 30th news release regarding 4 patients - not sure about a 5th one: Of the 4 patients that were removed from Study II, the clinical protocol in effect at the time stated in the patient withdrawal criteria that "Patients found to have at Day 90 new T1 high-grade disease, with or without CIS" and "Patients found to have unchanged or worsening CIS at 3 months" will ...more  
Comment by Kingpin68 on Feb 07, 2021 8:41am
Thanks Pandora. So it seems that the removed patients aren't calculated or included in the percentages of CR going forward then.
Comment by Oilminerdeluxe on Feb 07, 2021 10:49am
So with the wrong dosage, we have 44% CR? Some would say that with the correct dosage, we should move way, way, way better than that. Time to sell that kidney...
Comment by 99942Apophis on Feb 07, 2021 11:05am
Oilminerdeluxe you get a thumbs up for your sense of humor, wonder if this week we hear of another Canadian or American site added to the growing list of Phase 2 sites.
Comment by Oilminerdeluxe on Feb 07, 2021 11:07am
Would not mind that at all. Perhaps time to selll  b o t h  kidneys...
Comment by Eoganacht on Feb 07, 2021 11:54am
What a calamity for those 5 patients. They lost their opportunity to keep their bladders and be cancer free because of an "oversight" in the protocol.
Comment by Johnandrose22 on Feb 07, 2021 3:40pm
Thank you, Eoganacht, for your therapeutic splash of cold water in our faces. In the end, all of our discussions about this company and its trials are about real people battling a real plague called cancer. Those 5 patients who were dismissed from Phase II could have been any of us or any of our family members or those we love. There is no room or time for “oversights” at this point. The results ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250